Corporate Profile for Chiron, dated March 6, 1998.--(BUSINESS WIRE)--The following Corporate Profile is available for inclusion in your files. News releases for this client are distributed by Business Wire and also become part of the leading databases and online services, including all of the leading Internet-based services. -0-
Published Date: March 6, 1998
Company Name: Chiron Corp.
Address: 4560 Horton Street
Emeryville, CA 94608
Main Telephone
Number: 510/655-8730
Internet Home
Page Address
(URL) www.chiron.com
Chief Executive
Officer: Edward Penhoet, Ph.D.
Investor Relations
Contact: Jim Knighton
Business number: 510/923-3252
Public Relations
Contact: Julie Wood
Business number: 510/923-6686
Trading Symbol/
Exchange: CHIR/NASDAQ
Industry: Biotechnology
-0- Company description: Chiron Corp. is a global healthcare company with diagnostic and biopharmaceutical businesses. Its broad expertise enables an integrated approach to testing for, treating and preventing cancer, infectious and cardiovascular diseases. As a pioneer in the research and development of novel products, Chiron created the first genetically engineered genetically engineered adjective Recombinant, see there human vaccine for Hepatitis B Hepatitis B Definition Hepatitis B is a potentially serious form of liver inflammation due to infection by the hepatitis B virus (HBV). It occurs in both rapidly developing (acute) and long-lasting (chronic) forms, and is one of the most common chronic , discovered the Hepatitis C Hepatitis C Definition Hepatitis C is a form of liver inflammation that causes primarily a long-lasting (chronic) disease. Acute (newly developed) hepatitis C is rarely observed as the early disease is generally quite mild. genome and cloned and sequenced the entire HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States. genome. The company has more than 6,500 employees in facilities on four continents and markets products in 97 countries. In 1997, the company's total revenues were $1.2 billion. Chiron has a global partnership with the Swiss pharmaceutical company, Novartis, which owns approximately 49.9 percent of the company's outstanding common stock. Chiron Diagnostics is a worldwide supplier and developer of products used in clinical and research laboratories. In partnership with its customers, Chiron uses sophisticated technologies to improve clinical decision making and enhance patient management. The company is a dominant player in immunodiagnostics with high-throughput, random access immunodiagnostic immunodiagnostic pertaining to diagnosis by immune reactions. systems including its ACS (Asynchronous Communications Server) See network access server. :Centaur centaur (sĕn`tôr), in Greek mythology, creature, half man and half horse. The centaurs were fathered by Ixion or by Centaurus, who was Ixion's son. (tm) System. Its critical care systems provide vital information on the status of critically ill patients. The company's Quantiplex(R) nucleic acid nucleic acid, any of a group of organic substances found in the chromosomes of living cells and viruses that play a central role in the storage and replication of hereditary information and in the expression of this information through protein synthesis. diagnostics systems enables the quantification of virus. Through a joint business with Ortho Diagnostic Systems Inc., Chiron participates in the blood screening market. Chiron Biopharmaceuticals is a fully integrated global business with established vaccine and oncology franchises. The company's technology group provides research and development support for both businesses. Vaccines: Its vaccines' market presence is currently strongest in Europe, where it sells a variety of conventional and novel vaccines. The company also sells pediatric pediatric /pe·di·at·ric/ (pe?de-at´rik) pertaining to the health of children. pe·di·at·ric adj. Of or relating to pediatrics. and adult vaccines to multinational health organizations and local healthcare distributors around the world. Chiron uses its genetic expertise to develop safer and more effective vaccines that are designed to prevent as well as treat serious diseases. Therapeutics: Currently, Chiron markets oncology products in thirty countries worldwide. Its product line includes internally developed products such as Proleukin(R) (aldesleukin), currently approved for metastatic Metastatic The term used to describe a secondary cancer, or one that has spread from one area of the body to another. Mentioned in: Coagulation Disorders metastatic pertaining to or of the nature of a metastasis. kidney cancer and in the U.S. for metastatic melanoma. Betaseron(R) (interferon beta-1b) is another product manufactured by Chiron for the treatment of patients with relapse-remitting multiple sclerosis, which is marketed in the U.S. and Europe by partners. Technologies: Chiron's research team discovers and develops products using three core technology platforms: recombinant protein production, gene therapy and small-molecule discovery. Chiron has built its scientific expertise through a strong internal program and a broad collaborative network. When developed, its products are either sold by Chiron or licensed to marketing partners. PDGF PDGF platelet-derived growth factor; interacting with cell surface receptors and stimulating hydrolysis of inositol 1,4,5-triphosphate (IP3). , the active ingredient that Chiron manufactures for Ortho-McNeil's Regranex(R) (becaplermin), is an example of such a marketing collaboration. CONTACT: Chiron Corp. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion